FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

California Court Upholds Preemption for Medtronic

Attorney Michelle Yeary says a California state court granted Medtronic summary judgment on several product liability claims involving a spinal cord s...

latest-news-card-1
Human Drugs

Ashley Retiring as CDER Compliance Director

FDA announces the retirement of CDER Office of Compliance director Don Ashley.

latest-news-card-1
Human Drugs

FDA Looking at Marijuana Scheduling Flexibility: Woodcock

FDA principal deputy commissioner Janet Woodcock says the agency is exploring what flexibility it has in reviewing the science and health benefits of ...

latest-news-card-1
Federal Register

EUA Granted for Abbott Monkeypox Diagnostic

Federal Register notice: FDA announces an Emergency Use Authorization for Abbott Molecular and its Alinity m MPXV monkeypox diagnostic test.

latest-news-card-1
Human Drugs

Guide on C-diff Infection Drug Development

FDA makes available a draft guidance entitled Clostridioides difficile Infection (CDI): Developing Drugs for Treatment, Reduction of Recurrence, and P...

latest-news-card-1
Human Drugs

FDA Advancing Treatments for Children

FDA officials list ways in which the agency is promoting the development of pediatric medicines.

latest-news-card-1
Human Drugs

FDA Questions Y-mAbs Neuroblastoma Treatment Efficacy

FDA raises efficacy questions about a Y-mAbs BLA for I-omburtamab to treat pediatric patients with CNS/leptomeningeal metastases from neuroblastoma.

latest-news-card-1
Medical Devices

Digital Health Regulatory Science Opportunities

The CDRH Digital Health Center of Excellence releases a document highlighting topics of interest for regulatory science research and partnerships.

latest-news-card-1
Human Drugs

GSK Scraps Monoclonal Antibody Development for RA

GSK decides not to seek FDA approval for otilimab, an investigational monoclonal antibody targeting granulocyte-macrophage colony-stimulating factor a...

latest-news-card-1
Federal Register

Info Collection on 3rd Party Review Program

Federal Register notice: FDA sends to OMB an information collection extension entitled 510(k) Third-Party Review Program.